Login / Signup

Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.

Roy SchwartzZohar Habot-WilnerMichael R MartinezAmir NutmanDafna GoldenbergShai CohenShiri ShulmanHanan Guzner-GurAnat LoewensteinMichaella Goldstein
Published in: Acta ophthalmologica (2017)
In this study, eplerenone was not found to be superior to placebo in eyes with chronic CSC.
Keyphrases
  • high grade
  • clinical trial
  • drug induced
  • randomized controlled trial
  • study protocol